Aetiologies

  • Increased intake
    • Magnesium infusion
    • Massive oral ingestion
    • Unregulated absorption (eg. with peptic ulcer)
    • Milk-alkali syndrome
  • Compartment shift or leak
    • Tumour lysis syndrome
    • Rhabdomyolysis
    • Acidosis (shift out of cells)
  • Decreased loss
    • Renal failure
    • Primary Hyperparathyroidism (reabsorption in the tubule)
    • Lithium therapy
    • Hypoadrenalism
    • Familial hypocalciuric hypercalcemia

Can otherwise be classified:

  • Iatrogenic
    • Hyperalimentation
    • IV and oral magnesium
    • Laxatives, enemas, antacids (especially in elderly and renal failure)
  • Renal failure
  • Other
    • Perforated viscus with continued oral intake
    • Tumour lysis
    • Rhabdomyolysis

Clinical Features

Serum Magnesium LevelPhysiologic Effects
1.8-2.0 mmol/LAntiarrhythmic effects
Inhibition of parathyroid hormone secretion
Hypocalcemia
Ileus
2.0-4.0mmol/LHyporeflexia
Muscle weakness
Nausea
Flushing
Headache
Lethargy, somonolence
4.0-6.0mmol/LRespiratory failure
Hypotension
Bradycardia
Decreased level of consciousness
Bladder paralysis
6.0-10.0mmol/LApnoea
“Pseudocoma” … or actual coma
Parasympathetic blockade
Complete heart block
Cardiac arrest (asystole)
Over 10mmol/LLimits of the survivable
  • ECG changes are non-specific and often do not cause ECG changes
    • Can prolong QT interval and widen QRS complex

Management

  • In patients with normal renal function, renal clearance ensures rapid correction
  • Discontinue magnesium intake
  • However, in renal failure additional therapies are often required:
    • IV calcium
    • Insulin and glucose
    • Haemodialysis
    • Forced diuresis with IV normal saline and frusemide while monitoring for Hypocalcaemia

Sources